All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YF267 | Anti-MUC1×PSCA (HMFG2×1G8) h(CD28-CD3ζ) TanCAR, pCDCAR1 | Human | HMFG2 | Mouse | scFv (MUC1)-scFv (PSCA)-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF268 | Anti-MUC1×PSCA (HMFG2×bm2B3) h(CD28-CD3ζ) TanCAR, pCDCAR1 | Human | HMFG2 | Mouse | scFv (MUC1)-scFv (PSCA)-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF269 | Anti-MUC1×PSCA (SM3×bm2B3) h(CD28-CD3ζ) TanCAR, pCDCAR1 | Human | SM3 | Mouse | scFv (MUC1)-scFv (PSCA)-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF270 | Anti-MUC1×PSCA (HMFG2×hu1G8) h(CD28-CD3ζ) TanCAR, pCDCAR1 | Human | HMFG2 | Mouse | scFv (MUC1)-scFv (PSCA)-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF271 | Anti-MUC1×PSCA (SM3×hu1G8) h(CD28-CD3ζ) TanCAR, pCDCAR1 | Human | SM3 | Mouse | scFv (MUC1)-scFv (PSCA)-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF294 | Anti-MUC1×PSCA (HMFG2×1G8) h(41BB-CD3ζ) TanCAR, pCDCAR1 | Human | HMFG2 | Mouse | scFv (MUC1)-scFv (PSCA)-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF295 | Anti-MUC1×PSCA (HMFG2×bm2B3) h(41BB-CD3ζ) TanCAR, pCDCAR1 | Human | HMFG2 | Mouse | scFv (MUC1)-scFv (PSCA)-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF296 | Anti-MUC1×PSCA (SM3×bm2B3) h(41BB-CD3ζ) TanCAR, pCDCAR1 | Human | SM3 | Mouse | scFv (MUC1)-scFv (PSCA)-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF297 | Anti-MUC1×PSCA (HMFG2×hu1G8) h(41BB-CD3ζ) TanCAR, pCDCAR1 | Human | HMFG2 | Mouse | scFv (MUC1)-scFv (PSCA)-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF298 | Anti-MUC1×PSCA (SM3×hu1G8) h(41BB-CD3ζ) TanCAR, pCDCAR1 | Human | SM3 | Mouse | scFv (MUC1)-scFv (PSCA)-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF321 | Anti-MUC1×PSCA (HMFG2×1G8) h(CD3ζ) TanCAR, pCDCAR1 | Human | HMFG2 | Mouse | scFv (MUC1)-scFv (PSCA)-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF348 | Anti-MUC1×PSCA (HMFG2×1G8) h(CD28-41BB-CD3ζ) TanCAR, pCDCAR1 | Human | HMFG2 | Mouse | scFv (MUC1)-scFv (PSCA)-CD28-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF349 | Anti-MUC1×PSCA (HMFG2×bm2B3) h(CD28-41BB-CD3ζ) TanCAR, pCDCAR1 | Human | HMFG2 | Mouse | scFv (MUC1)-scFv (PSCA)-CD28-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF350 | Anti-MUC1×PSCA (SM3×bm2B3) h(CD28-41BB-CD3ζ) TanCAR, pCDCAR1 | Human | SM3 | Mouse | scFv (MUC1)-scFv (PSCA)-CD28-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF351 | Anti-MUC1×PSCA (HMFG2×hu1G8) h(CD28-41BB-CD3ζ) TanCAR, pCDCAR1 | Human | HMFG2 | Mouse | scFv (MUC1)-scFv (PSCA)-CD28-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF352 | Anti-MUC1×PSCA (SM3×hu1G8) h(CD28-41BB-CD3ζ) TanCAR, pCDCAR1 | Human | SM3 | Mouse | scFv (MUC1)-scFv (PSCA)-CD28-41BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF375 | Anti-MUC1×PSCA (HMFG2×1G8) h(CD28-OX40-CD3ζ) TanCAR, pCDCAR1 | Human | HMFG2 | Mouse | scFv (MUC1)-scFv (PSCA)-CD28-OX40-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF376 | Anti-MUC1×PSCA (HMFG2×bm2B3) h(CD28-OX40-CD3ζ) TanCAR, pCDCAR1 | Human | HMFG2 | Mouse | scFv (MUC1)-scFv (PSCA)-CD28-OX40-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF377 | Anti-MUC1×PSCA (SM3×bm2B3) h(CD28-OX40-CD3ζ) TanCAR, pCDCAR1 | Human | SM3 | Mouse | scFv (MUC1)-scFv (PSCA)-CD28-OX40-CD3ζ | Lentiviral vector | T Cell | ||
CAR-YF378 | Anti-MUC1×PSCA (HMFG2×hu1G8) h(CD28-OX40-CD3ζ) TanCAR, pCDCAR1 | Human | HMFG2 | Mouse | scFv (MUC1)-scFv (PSCA)-CD28-OX40-CD3ζ | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION